Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity

Chia Yee Tan(National University of Singapore), Jianming Jiang(Hebei Medical University)
Journal of Translational Medicine
October 15, 2023
10.1186/s12967-023-04542-4
Cited by 15

Related Papers

De novo mutations in histone-modifying genes in congenital heart disease
|Nature|2013|958
Allele-Specific Silencing of Mutant <i>Myh6</i> Transcripts in Mice Suppresses Hypertrophic Cardiomyopathy
|Science|2013|229
Hypertrophic cardiomyopathy mutations in <i>MYBPC3</i> dysregulate myosin
|Science Translational Medicine|2019|215
mTORC1 Dependent Regulation of REDD1 Protein Stability
|PLoS ONE|2013|35